9-anilinoacridine has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwell, GJ; Baguley, BC; Denny, WA; Rewcastle, GW | 1 |
| Baguley, BC; Denny, WA; Johnson, P; Lee, HH; McFadyen, WD; Palmer, BD; Wakelin, LP; Wickham, G | 1 |
2 other study(ies) available for 9-anilinoacridine and Leukemia P388
| Article | Year |
|---|---|
Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; DNA; Female; Leukemia L1210; Leukemia P388; Male; Mathematics; Mice; Structure-Activity Relationship | 1984 |
DNA-directed alkylating agents. 2. Synthesis and biological activity of platinum complexes linked to 9-anilinoacridine.
Topics: Alkylating Agents; Amsacrine; Animals; Chelating Agents; Chemical Phenomena; Chemistry; Cisplatin; Diamines; DNA; Drug Resistance; Ethylenediamines; Leukemia P388; Magnetic Resonance Spectroscopy; Molecular Structure; Organoplatinum Compounds; Spectrophotometry, Ultraviolet | 1990 |